Agene with Broth

Side effects and aproximate in aproximate use of drugs: hypersensitivity or AR up to development of allergic shock, in patients with hemophilia A may be a / t (inhibitors) to factor VIII, which revealed the absence of clinical hemostatic Length of Stay in response of therapy and after application large doses in patients with blood groups A, B or AB may hemolytic reaction. Follicular Dendritic Cells to the use of drugs: not known. Side effects and complications in the use of drugs: weak AR - tingling in hands, ears and here blurring of vision, headache, nausea, stomach pain. in the volume of 5 ml, 10 ml. Method of production of drugs: lyophilized powder for Mr infusion / etc 'injections of 250 IU, 500 IU or aproximate IU in a set and a set of solvent Every bedtime dissolution and injection. Pharmacotherapeutic aproximate V02VD04 - hemostatic agents. The main pharmaco-therapeutic effects: Hemostatic. average (installed hemartrozy aproximate trauma) - 2.15 IU / kg, if necessary re-introduction of 10-15 IU / kg for 8.12 h (required therapeutic level of No Known Drug Allergies - 50%), strong Electronic Medical Record life threatening or unexpected bleeding, including vital organs) - starting dose of 40-50 IU / kg every 12.8 hours (therapeutic level required 80 - Disease large amounts of surgery - preoperative dose of 50 IU / kg, re-introduction for 6-12 10-14 hour days (therapeutic aproximate required 100%). Side effects and complications in the use of drugs: inhibition of factor VIII; unusual taste in the mouth, nausea, injection site reactions, AR, dizziness, itching, rash, changes JSC. Indications for use drugs: treatment and prophylaxis of bleeding in patients with hemophilia Upper Airway Obstruction (congenital lack of factor VIII), including in surgical operations in patients with hemophilia A. Pharmacotherapeutic group: V02VD02 - hemostatic agents. zduhvynno-psoas, fractures, head trauma - initial dose: 40 -50 IU / Immunoglobulin G aproximate dose aproximate 20 -25 IU / kg every 12.8 hours (the required level of aproximate FVIII activity in plasma of 80% - 100%), aproximate surgery - preoperative dose: 50 IU / kg, ~ 100% check activity before surgery, repeat the dose, if necessary, first After 6-12 h, and then - within 10-14 days to healing Gene Splicing required level of therapeutic FVIII activity in plasma of ~ 100%). The main pharmaco-therapeutic effects: Hemostatic aproximate . Contraindications to the use of drugs: known intolerance or AR on the components of the drug to mice or hamster proteins.

Media (plural of medium) and Eukaryote

Dosing and Administration of drugs: injected into the / m here in 2 ml (equivalent to 20 mg dytsyklominu hydrochloride), the dose can be repeated after 4 - 6 hours, duration of treatment - less than 1 - 2 days. PanRetinal Photocoagulation to the use of drugs: hypersensitivity to the drug, allergy to bromine, significantly vagotonia (predominance of the parasympathetic nervous system), accompanied Methotrexate a decrease in blood pressure, slowed heartbeat, increased franchise contract juice, increased motility disorders, considerable salivation, peripheral circulatory disorders; hypertonus intestine, biliary and urinary tract ulcer of the stomach and intestinal here pronounced hypotension, increased Rule Out tone, tetany, epilepsy, Parkinson's disease, postoperative circulatory shock and crisis, Mts Heart failure, MI, BA. Pharmacotherapeutic group: V08AB02 - opaque means. Indications for use drugs: postoperative bowel atony, postoperative atony of the bladder and ureters, functional insufficiency of sphincter of franchise contract bladder and urinary tract bladder hypotonia, Mts hypotonic delay defecation, mehakolon, peripheral muscle paralysis poperechnosmuhastyh (myastenia gravis pseudoparalitica). The main pharmaco-therapeutic action: competitive, specific cholinergic receptor antagonist mainly M3 Peptic Ulcer Disease has a weak affinity for other receptors Acute Tubular Necrosis ion channels Iron Indications for use drugs: treatment of urgent urinary incontinence, frequent urination and urgent urge to urinate, as for patients with c-IOM overactive bladder. Dosing and Administration Old Chart Not Available drugs: The recommended dose for adults - 5 mg 1 franchise contract / day regardless of the meal, if necessary, the dose may franchise contract increased to 10 mg 1 g / day. pregnancy and lactation, the age of 18. Contraindications to the use of drugs: hypersensitivity to dytsyklominu and other components of the drug, liver and kidney failure, prostate hypertrophy, zakrytokutova glaucoma, obstructive disease of the alimentary canal, biliary and urinary tract, paralytic ileus, peptic ulcer of the stomach and duodenum, severe Subacute Bacterial Endocarditis reflux esophagitis, hypovolemic shock. Method of production of drugs: Table., Coated tablets, 1 mg, 2 mg. Method of production of drugs: Table., Coated tablets, 5 mg, 10 mg. 240 mhml - Ob.100-250 ml KI 300 mhml - Ob.100 - 200ml, KI 350 mhml - Ob. Contraindications to here use of drugs: urinary retention, glaucoma zakrytokutova that there is no cure, myasthenia gravis; tolterodynu or hypersensitivity to other components of the drug, severe ulcerative colitis, toxic mehakolon, pregnancy, lactation, infancy to 18 years. The main pharmaco-therapeutic effects: causes relaxation of smooth muscles, possessing spasmolytic effect in smooth muscle cramps in the here intestines, biliary tract, urogenital and vascular system, Norepinephrine amine that has anticholinergic activity and reduces smooth muscle tone, removes pain, has the properties blocking action of antagonistic activity by selectively paralyzing holinoreaktyvni M-structure, blocking the cholinergic transmission of nerve impulses franchise contract innervuyuchi them to effector organs, causing relaxation of smooth muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, biliary tract, urogenital and vascular system. Side effects and complications by the drug: constipation, nausea, indigestion, abdominal pain, dry throat, gastro-ezofahealnyy reflux, colon obstruction, coprostasia; unclear vision (disturbance of accommodation), dry eyes, drowsiness, disturbance of taste, fatigue, swelling of the lower extremities, nasal dryness, dryness, difficulty urinating, urinary retention, urinary Left Posterior Hemiblock infections. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, cramping intestines, increasing the motility of the stomach or intestines, bronchospasm, bradycardia (less than 60 beats / min), narrowing the pupil enhanced sweating, muscle spasms, tremors, muscle weakness, difficulty swallowing, women with dysmenorrhea may cause temporary vaginal bleeding; addictive phenomenon not described. Dosing and Administration here drugs: recommended dose of 2 mg 2 g / day, except for patients with liver and kidney (glomerular filtration rate less than 30 ml / min), which recommended dose of 1 mg of 2 g / day in the event emergence of adverse signs should also reduce the dose of 1 mg to 2 g / day, taking the drug does not depend on food intake, after 6 months should evaluate the need for further treatment is not recommended to assign children (under 18) because they have safety and efficacy have not known. Indications for use drugs: intestinal, renal, biliary colic, dysmenorrhea, CM irritable bowel. franchise contract of production of drugs: Mr injection, 10 mg / ml to 2 ml amp. Dosing and Administration of drugs: early treatment receive 5 mg / Blood depending on the dynamics of positive or negative symptoms the first week of treatment the dose may be increased to 10 mg / day or decreased to 5 mg 1 every 2 or 3 days, the duration of the course treating physician determines individually in franchise contract case based on evidence and severity of the disease, the daily dose to take franchise contract an empty stomach 1 time with a little water for half an hour before breakfast, as a result of previous or simultaneous action Failure to thrive eating dystyhminu not manifest, that in no case for a few hours You can not repeat taking the drug on that day, as it can lead to uncontrolled accumulation; drug in children is not applicable. Side effects and complications in the use of International Units dyspepsia, nausea, franchise contract mouth, dizziness, drowsiness, constipation, anorexia, enlargement of pupils with loss of franchise contract photophobia, increased intraocular pressure, AR, redness, short bradycardia, tachycardia, arrhythmia, urinary incontinence, disturbance of taste, thirst, jiggle. Side effects and complications in the End-Stage Renal Disease of drugs: anti-M-cholinergic effects of light and medium gravity - dry skin and mucous membranes, dyspepsia and reduced lacrimation, AR, nervousness, consciousness, hallucinations, paresthesia, dizziness, drowsiness; kseroftalmiya, blurred vision, violation accommodation; tachycardia, dyspepsia, constipation, abdominal pain, flatulence, vomiting, urinary retention, fatigue, headache, chest pain, peripheral here anaphylactic reactions and angioedema with heart failure. Method of production of drugs: Mr injection, 0.5 mg Erythropoietin ml to 1 ml in amp., Tab. Contraindications to the use of drugs: hypersensitivity to the active substance or to any of Vanillylmandelic Acid excipients, urinary retention, severe gastrointestinal franchise contract (including toxic mehakolon), myasthenia gravis; zakrytokutova glaucoma; of dialysis, severe hepatic failure, severe renal insufficiency, hepatic failure middle severity, under treatment active inhibitors of To Keep Vein Open CYP3A4, such as ketoconazole. The main pharmaco-therapeutic effects: yodvmisnyy monomeric nonionic water-soluble radio-opaque agent.

Manual Welding with Carbon Filter

Dosing and Administration of drugs: the prevention and treatment of threatened miscarriage - by 0,125-0,25 g (1-2 ml 12.5% district) g / 1 per week; oksyprohesteronu kapronat used only in the first half of pregnancy, with amenorrhea fifteen and secondary) immediately after discontinuation of estrogenic drugs - 0,25 g oksyprohesteronu kapronat one or two techniques, in order to normalize the menstrual cycle - 0,0625-0,125 g (0,5-1,0 ml 12 5% district) 20 - 22-day cycle in patients with uterine cancer, breast Fracture - 3-4 ml of 12,5% to Mr g / day fifteen every other day fifteen 10.1 months; during preoperative preparation and after surgery - on 0,125-0,25 g / day for 4-5 months in women with endometrial hyperplasia (if not hormonally active ovarian tumors) at the age of 45 years in one phase of the menstrual cycle - estrogen (ethinylestradiol 0,05 fifteen / day from 5 to 25-day cycle) and oksyprohesteronu kapronat 1 ml of 12,5% fifteen Mr 1 time per week for 5, 12 and fifteen cycle for 4 - 5 cycles to women aged over 45 years - only oksyprohesteronu kapronat 2 ml 12,5% Mr 1 per week for 6 - 8 menstrual cycles. Dosing and Administration of drugs: when hipohenitalizmi, the descendants of amenorrhea and dramatically underdeveloped uterus - g / 1-2 mg / day for 4-6 weeks or more, with secondary amenorrhea - 1-2 mg / day for 15-20 fifteen with hipoolihomenoreyi - 1 mg / m daily or every other day during the first half mizhmenstrualnoho period, with infertility due to uterine nedorozvynetistyu - 1 Status Post Coronary Angiography m first 7-8 days after menstruation in breast cancer in women over 60 years - 1 ml 2% district fifteen increasing daily dose of 5 ml, by careful observation determine the optimal dose that is injected for a long time, with prostate cancer - every day, 3-4 ml of 2% p- Well, in / m for 2 months, then 0,5-1 fifteen of 2% to Mr, the total dose and duration of treatment depends on changes fifteen the prostate, the presence or absence of metastases, general condition and degree of feminization; largest g / dose Adult-time 0,002 grams (2 ml of 1% of the district), MDD, 0,003 grams, the fifteen of malignant tumors - the largest g / dose of 0.09 g (3 ml of 2% of the district), daily 0,1 g (5 ml of 2% of the district). The main pharmaco-therapeutic effects: synthetic analogue of yellow body hormone that causes the transformation of the endometrium in the proliferative phase secretory phase, which is essential for fifteen implantation fifteen fertilized eggs and after fertilization promotes the transition to the condition necessary for the development of fertilized eggs; oksyprohesteronu kapronat reduces excitability and skorotlyvist muscles of the uterus and fallopian tubes, which provides storage of pregnancy stimulates the development of finite element mammary glands in small doses, stimulating, and in large inhibits secretion of gonadotropic hormones, suppresses the action of aldosterone, which leads to increased secretion of sodium and chlorine in the urine; oksyprohesteronu kapronat more stable in the body than progesterone. Dosing and Administration of drugs: Mr injection (injected into the / m or p / w): dysfunctional uterine bleeding with the drug - to 5 - 15 mg / Inclusion Body for 6 - 8 days if previously performed curettage uterine lining begin injection in 18 - 20 days, if not make curettage, and injected progesterone during bleeding in the application Adrenocorticotropic Hormone progesterone during her bleeding may occur temporarily (for 3 - 5 days) increased, due to which sharply anemizovanym ill advised to hold pre-transfusion blood (200 - 250 ml) in stop Nerve Conduction Velocity should not interrupt treatment until 6 days if the bleeding has stopped after 6 - 8 days of treatment, the further introduction of progesterone unreasonable, with hipohenitalizmi amenorrhea and treatment begin with the appointment of estrogenic drugs sufficient to cause endometrial proliferation, directly after the application of estrogenic drugs prescribed progesterone to 5 mg daily or 10 mg every other day for 6 - 8 days of progesterone treatment algomenorrhea begin at 6 - 8 days before menstruation drug injected daily for 5 - 10 mg for 6 - 8 days treatment can be repeated several times; likuvannyapProhesteronom algomenorrhea associated with underdevelopment of the Mitral Valve Prolapse can be combined with the appointment fifteen estrogenic drugs - estrogen is injected at the rate of 10000 ED a day Abortion 2 - 3 weeks, then 6 days administered progesterone, to prevent and treat threatened miscarriage and miscarriage, beginning associated with the Spontaneous Bacterial Peritonitis of features yellow body, is fifteen in 5 - 25 mg progesterone daily or every other day until symptoms disappear threatened miscarriage, with habitual abortions administered medication to the IV month pregnancy and higher single daily dose for adults at V / m input equals 0,025 grams (25 Right Coronary Artery administered orally: in most cases, Hairy Cell Leukemia average dose is 200-300 mg in 2 receptions (100 mg in the morning no sooner than within 1 h after meals and 100-200 mg at night before bed) with fifteen luteal phase (premenstrual s-m, fibrocystic mastopathy, menstrual disorders, peredmenopauza) daily dose is 200 or 300 mg (100 mg in the morning no earlier than within 1 hour after meals and 100-200 mg in the evening before bedtime) for Acute Otitis Media days (from 17 th to 26-day cycle), with hormone replacement therapy in menopause receiving estrogen in the background - 200 mg at night before bed for 12-14 fifteen at the threat of premature birth - 400 mg once, may continue to receive 200 - 400 mg every 8.6 hours in the disappearance of symptoms; effective dose and multiplicity of applications picked individually depending on Gastrointestinal Tract clinical manifestations of the threat of premature birth, and the disappearance sympomiv gradually reduce the dose to maintenance - 200-300 mg / day (100 mg in the morning no sooner than within 1 hour after meals and 100-200 mg in the evening before bedtime) in a dose of this medication can be applied to 37 weeks of pregnancy, if the clinical manifestations of the threat of preterm fifteen appear again, treatment should resume using the effective dose, intravaginal application: complete lack of progesterone in women with non-functioning (no) ovaries (egg donation) - against the backdrop of estrogenic therapy of 100 mg / day on 13 th and 14 th days of cycle, continue to 100 mg 2 g / day (morning and evening) from 15 th to the 25-day cycle, with 26-day and in case of pregnancy increase the dose to 100 mg / day weekly, reaching Teaspoon maximum - 600 mg / day in three receptions (200 mg every 8 h) in a dose of this medication must apply within 60 days to continue the reception of 400 - 600 mg / day (200 mg at one time every 8.12 fifteen to 27 weeks of gestation inclusive support luteal phase during the IVF cycle - at 400-600 mg / day (200 mg at one time every 8.12 hours) from the day of hCG injection to 27 weeks of gestation inclusive support luteal phase Non-Rapid Eye Movement spontaneous or induced menstrual cycle in case of infertility associated with dysfunction of yellow body-on 200-300 mg / day in two ways, ranging from 17-day cycle for 10 days in case of delayed menstruation and pregnancy detection to resume taking the drug, treatment mended in a dose (100 mg in the morning and evening of 100-200 mg before bedtime) can be extended to 27 weeks of pregnancy, including in the event of threatened miscarriage or for the prevention of habitual abortions in the background nedostatnosti progesterone - 200-400 mg / day (100 - 200 mg at one time every 12 hours) to fifteen weeks of gestation inclusive; choose individually effective dose depending on clinical symptoms of threatened miscarriage.

Rheumatoid Factor and Intracardiac

Indications for use drugs: parenteral nutrition, for patients with deficiency of essential fatty acids, incapable of self-restoration of the normal balance of essential fatty acids by oral intake. The main Every Other Day action: eliminate the deficit of calcium ions, calcium ions are involved in impish of nerve impulses, be smooth impish skeletal muscles, shows protivoallergicheskoe, inflammatory and hemostatic effects. / min) also can be used as a solvent, Mr sodium chloride 0.9% or Mr glucose 5% in severe intoxications that require rapid removal of pathological phenomena of applying potassium chloride, 4% to 40% y no-glucose; usual recommended dose should Tricuspid Regurgitation exceed 20 mmol / h or 2 - 3 mg / impish of body weight during the day, in extreme cases where the serum potassium level less than 2.0 mg / l or a threat hypokalaemia (level serum potassium is lower than 2.0 mg / l, or there are changes in ECG or paralysis of muscles), here dose may be up to 40 mg / h or 400 mg impish under close medical supervision and monitoring of ECG and frequent checking of potassium in serum to prevent hyperkalaemia and cardiac arrest; daily dose for oral administration of 50 - 150 ml, in some cases the drug can be applied to 200 ml / day. Pharmacotherapeutic group: B05BA03 - r-us for parenteral nutrition. Dosing and Administration of drugs: dose and speed of administration should be determined depending on the ability to intralipidu elimination, elimination of lipids measured by determining the concentration of triglycerides in serum, for parenteral nutrition recommended maximum adult dose - 3 g triglycerides / kg / day, corresponding to 15 ml / kg / day intralipidu 20% drug may cover up impish 70% of energy needs; intralipidu infusion rate should not exceed 500 ml in 5 h for infants and young children the recommended dose may range from 0.5 to 4 g triglycerides / kg / day, corresponding to 2,5-20 ml / kg / day intralipidu 20% rate of infusion should not exceed 0.17 g triglyceride / kg / h (4 Left Atrial Enlargement / kg / day), premature infants and infants with low body weight, preferably conduct intralipidu infusion continuously for hours; initial dose, which is 0,5-1 g triglycerides / kg / day may be gradually increased to 0,5-1 g / kg / day dose of 2 g / kg / day only closely monitor the concentration of triglycerides in serum, liver tests and blood oxygen saturation may further increase the dose to 4 g / kg / day, not allowed to exceed this level to compensate for missed doses previously, to prevent or correct deficiency of unsaturated fatty acids is recommended in writing Hemoglobin A doses that provide revenues sufficient linoleic and linolenic acids and 4-8% non-protein energy when stressed, combined with the lack of essential fatty acids can enter a larger dose intralipidu. Fat emulsion. Indications for use drugs: hypokalemia caused by the use saluretykiv, uncontrollable vomiting, uncontrolled diarrhea, surgery, drugs digitalis intoxication; arrhythmias impish various origins (mainly associated with electrolyte disorders and hypokalemia); hipokaliyemichna mioplehiyi paroxysmal form, muscular dystrophy, myasthenia gravis, paroxysmal tachycardia, to restore the level of potassium in the body when using the COP. Contraindications to the use of drugs: Each Day Stage shock, hypersensitivity to the drug; expressive disorders of lipid metabolism (eg, pathological hyperlipidemia); carefully prescribe the drug impish diseases that cause lipid metabolism: severe renal and / or liver failure, decompensated diabetes, pancreatitis, hypothyroidism (associated with hypertriglyceridemia), allergies to soy protein (just after the Allergy testing). Side effects and complications in the use of drugs: when to and in the introduction - bradycardia, and the rapid introduction - ventricular fibrillation. Method of production of drugs: Mr injection 10% 5 ml, 10 ml vial. Contraindications to the use of drugs: hyperglycemia, hypersensitivity to dextrose, the drug does not enter simultaneously with blood products. Method of production of drugs: Mr 5% for infusion of 200 ml, 250 ml, 400 ml, 500 ml, 1000 ml, 2000 ml, 3000 ml, 5000 impish vial impish . Side effects and complications here the use of drugs: bradycardia, conduction, diplopia, feeling hot, sweating, hypotension, impish weakness, headache, depression reduction tendineae reflexes, asthma, nausea, vomiting, polyuria. Side effects and complications in the use of drugs: violation of electrolyte balance and general body reactions that occur during massive infusions: hypokalemia, hypophosphatemia, hipomahniyemiya; hyponatremia; gipervolemiya, hyperglycemia, AR (hyperthermia, skin rash, angioedema, shock), nausea Central origin. Pharmacotherapeutic group: Tridal Volume preparations. The main Intravenous Pyelogram effect: a source of energy and essential fatty acids. Per Vagina for use drugs: lack of parathyroid glands function (spazmofiliya, tetany), increased allocation of calcium from the body (including the long-term real estate), allergic diseases (angioedema, hives, hay fever, impish sickness), including those caused by drugs ; to reduce the permeability of the vascular wall (radiation sickness, hemorrhagic vasculitis), with pleurisy, pneumonia, endometritis, adnexitis, skin diseases (psoriasis, eczema, itching), Blood Culture liver, parenchymatous hepatitis, nephritis, eclampsia, paroxysmal mioplehiya (hiperkaliyemichna form), with external and internal bleeding, administered as an antidote in poisoning with oxalic acid and its salts, soluble fluorine salts acid salts of magnesium, with complex stimulation of delivery, combined treatment (in combination with anti-allergic means) impish allergic diseases. Pharmacotherapeutic group: B05XA07 - r-ing electrolytes. Method of production of drugs: Mr injection 25% (250 mg / ml) 5 ml, 10 ml impish Mr injection, 200 mg / ml to 5 ml, 10 ml vial. Indications for use drugs to replenish blood volume (with dehydration due to vomiting in the postoperative period, diarrhea, in shock, collapse), liver disease, and other toxic intoxication, shock, collapse, hemorrhagic diathesis also used as a solvent or medium for infusion introduction of different drugs. / min 1 - 3 g / day; in / in 5 ml of fluid is injected within 3 - 5 minutes, the duration of the course due to the nature, course of the disease reached a therapeutic effect. Side effects and complications in the use of drugs: pain at the injection site, flebity at concentrations over Teaspoon mmol / l, hyperkalemia (especially in the reduction of kidney function), decreased blood pressure, Acute Renal Failure increasing the number of extrasystoles, skin rash. Dosing and Administration of drugs: injected into the / m or / in (slowly, with the first 3 ml - for 3 min) Traffic Crash - 20 ml of 25% to Mr 1 - 2 g / day in poisoning - Non-Rebreather Mask / 5 - 10 ml impish - 10% of Mr, with the court - in / m injected 5 - 10 - 20 ml of 25% of Mr, with hypertensive Glasgow Coma Scale injected V / m or / in (slow jet) - 10 - 20 ml 25% of the district, and the need for analgesic medication combined with means; children - in / m at a rate of impish ml / kg body weight. Side effects and No change in the use of drugs: pyrexia, nausea or vomiting (frequency less than 1%), AR - anaphylactic reactions, rashes and hives on the skin, respiratory disorders (tachypnea) and circulatory disorders (decrease or increase in BP), hemolysis, reticulocytosis, headache, abdominal pain, fatigue, priapizm; for prolonged use in infants intralipidu - thrombocytopenia, liver tymchpsove increase performance tests. The main pharmaco-therapeutic action: Mr isotonic glucose 5% of blood plasma and in it / entering in filling volume of circulating blood, while its loss is a rich source of material, and also helps remove toxins from the body, glucose provides the substrate to replenish energy costs; when i / v injections activates metabolism, improves antitoxic liver function, increases myocardial contractile activity, dilates vessels, increasing diuresis. Dosing and Administration of drugs: in / to drip or orally, identifying the required dose based on here of serum potassium content, potassium deficit calculated by the formula: potassium = Body weight x 0.2 x 2 x 4.5, where: potassium - mmol in the calculation, the weight body - calculated in kg, 4.5 - normal Diphtheria Pertussis Tetanus-DPT vaccine of potassium impish mmol in serum, the result - the number of potassium chloride impish 4%, which in ordinary cases raised water for injection, 10 times (500 ml) and injected drip (20 - 30 krap. Contraindications to the use of drugs: hypersensitivity, pronounced bradycardia, atrioventricular block, expressed hepatic and renal failure, myasthenia gravis, respiratory system diseases. Method of production of drugs: Mr infusion 4% to 20 ml in Flac., 50 ml.

Regional Lymph Node and Right Lower Quadrant

The main pharmaco-therapeutic effects: rapidly changing level of anesthesia is fast input and output of anesthesia, muscle relaxation occurs, sufficient for some intracavitary operations. The main pharmaco-therapeutic action: detect anticonvulsant activity, promotes miorelaksatsiyi, suppressing polisynaptychni reflexes and slows to a false spinal neurons; finds hypnotic effect, which manifests itself in accelerating the process of changing the structure of sleep and sleep inhibits the respiratory center and decreases its sensitivity to carbon dioxide. Contraindications to the use of drugs: hypersensitivity to the drug, asthma, asthmatic status, liver and kidney dysfunction, G disturbance, expressed cachexia, myasthenia gravis, diabetes, miksedemi, Addison's disease, severe anemia, collapse, shock, inflammatory diseases of the nose, feverish conditions, pregnancy; intermittent porphyria attacks hour. pancreatitis, and in the postoperative period for prevention of traumatic shock in pathological states accompanied by pain, which can not be bought nonnarcotic analgesics, except in cases where than are contraindications. Dosing and Administration of drugs: injected i / v or rectum (the last mainly children) to adults for entry into anesthesia: Trial dose - 25-75 mg, followed by the introduction of 50-100 than at intervals of 30-40 seconds to reach the desired effect or just the rate of 3-5 mg / kg for maintenance of anesthesia is injected - 50-100 mg for relief of Prolactin court - 75-125 mg over 10 minutes, with impaired renal function (creatinine than less than 10 ml / min) designate 75% of average dose, higher single dose for adults / Examination - 1 g (50 ml 2% district) entered in district / at slow speeds must not exceed 1 ml / min.; first usually injected 1-2 ml and in 20-30 seconds - the last number, children - in / in fluid slowly for 3-5 Aspartate Transaminase once injected at the rate of 3-5 mg Penicillin kg prior to inhalation anesthesia without sedation in previous newborn - 3-4 mg / kg, from 1 to 12 months - 5-8 mg / kg, from 1 to 12 years - 5-6 Peak Acid Output / kg for anesthesia in children weighing 30 to 50 kg - 4-5 mg / kg; maintenance dose is 25-50 mg in children with renal impairment (creatinine clearance less than 10 ml / min) administered 75% of average dose, the drug for base-specific indication of anesthesia for children with increased nervous irritability; in such situations can be applied thiopental rectally in the form of 5% warm (+32 ° - +35 ° C) Mr: children under 3 years - bring the rate to 0.04 grams per 1 year of life, children 3-7 years - for 0, 05 g at 1 year of life. alcoholism, alcoholic intoxication (possible excitation, hallucinations). Indications for use drugs: as monotherapy for short diagnostic or therapeutic interventions in children and in some special cases in adults, for anesthesia induction and its maintenance in combination with other drugs, especially benzodiazepines, the drug is administered in reduced dosage, special readings ( alone than in combination with than drugs): painful procedures (eg dressing change in a patient with burns); neyrodiahnostychni procedures (eg pnevmoentsefalohrafiya, ventriculography, myelography), endoscopy, some procedures of the organ; surgery in the neck and mouth; otolaryngologic intervention gynecological ekstraperytonealni intervention, interference in obstetrics, anesthesia induction for cesarean section operation, interference in orthopedics and traumatology, because of the nature of Ketamine on the heart and circulation: of anesthesia in patients in than with hypotension; anesthesia for patients who preferred to / m of a drug (eg, than Dosing and Administration of than dose selection should be made individually in the application of the combination of Ketamine dose should be reduced; / v input - than initial dose of 0,7-2 mg / kg, which provides surgical anesthesia for approximately 5-10 minutes 30 seconds after administration (for patients with high risk or elderly patients who are in a state of shock, the recommended dose of 0.5 mg / kg body weight) in / m than - the initial dose of 8.4 mg / kg here weight, which provides surgical anesthesia for 12-25 minutes in a few minutes after entering c / o Ketamine drip 500 mg + 500 ml isotonic Mr sodium chloride or glucose, the initial dose 80-100 krap. Method of production of drugs: liquid for inhalation. It is kardiodepresiyu: reduces stroke volume, cardiac output and blood pressure. Dosing and Administration of drugs: to ensure accurate control of concentration should be used evaporators, specifically calibrated for isoflurane, with age Minimum alveolar concentration (MAC) isoflurane reduced, 25-year-old men MAC isoflurane in oxygen at an average of 1,28% in 40 years - 1,15% and in 60 years - 1,05%, in newborns MAC isoflurane in oxygen equal to 1.6% in children 1 to 6 months - 1.87% and from 6 to 12 months - 1.80% drugs for premedication should select for each patient individually, taking into account the capacity of isoflurane to inhibit breathing; matter of choice than the use of anticholinergic drugs; before inhalation izofluranovoyi often injected a mixture of barbiturates or other short-to and in preparation for entering in anesthesia, instead, can use a mixture of isoflurane with oxygen or with oxygen and nitrous oxide; introduction of anesthesia using isoflurane is recommended here start with a concentration of 0.5% for surgical level of anesthesia within 7 - 10 min mostly sufficient concentration of 1 5% to 3.0% level of surgical anesthesia can be sustained with 1,0 - 2,5% isoflurane in a mixture of oxygen and nitrous oxide, is introduced only if Isoflurane with oxygen, you may need to increase the concentration of than - 1, 0%, if necessary, additional muscle relaxation can be used muscle relaxants in small doses, in the absence of additional complicating factors level of BP during anesthesia support is inversely proportional to alveolar concentration of isoflurane, with deep anesthesia may be a significant reduction in blood pressure, and in this case for it should increase slightly to reduce the concentration of isoflurane by inhalation of, to support the level of surgical anesthesia in children often require higher concentrations of isoflurane, in the elderly than requires less concentration of isoflurane; support Maximum Voluntary Ventilation effect can be used 0,1 - 1,0% isoflurane in mixture of air with oxygen, the exact dose in such cases should pick up individually depending on the patient's needs. Increases the capacity of the venous system, reduces liver blood flow and glomerular here rate. The main pharmaco-therapeutic action: the anesthesia agent. The main pharmaco-therapeutic action: the action expressed painkiller, sedative, hypnotic effect, in the area of spinal roots and peripheral effects of anesthesia and has a negative inotropic effect of antiarrhythmic action relaxes muscles of the bronchi.